Friday, July 29, 2016

Blood Cancer Journal - Table of Contents alert Volume 6 July 2016

If you are unable to see the message below, click here to view.
Blood Cancer Journal


Volume 6, July 2016

In this issue
Original Articles
Letters to the Editor
Sign up for e-alerts Sign up for e-alerts
Web feed
Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders.

Explore the benefits of submitting your next research article.



‘Acute myeloid leukemia: a comprehensive review and 2016 update’

I De Kouchkovsky and M Abdul-Hay

Blood Cancer J 2016 6: e441; 10.1038/bcj.2016.50

Abstract | Full Text

New investigational drugs with single-agent activity in multiple myeloma

A M Rajan and S Kumar

Blood Cancer J 2016 6: e451; 10.1038/bcj.2016.53

Abstract | Full Text

Original Articles


Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome

C Y Cher, G M K Leung, C H Au, T L Chan, E S K Ma, J P Y Sim, H Gill, A K W Lie, R Liang, K F Wong, L L P Siu, C S P Tsui, C C So, H W W Wong, S F Yip, H K K Lee, H S Y Liu, J S M Lau, T H Luk, C K Lau, S Y Lin, Y L Kwong and A Y H Leung on behalf of the Hong Kong AML Study Group

Blood Cancer J 2016 6: e442; 10.1038/bcj.2016.51

Abstract | Full Text

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Y Jethava, A Mitchell, M Zangari, S Waheed, C Schinke, S Thanendrarajan, J Sawyer, D Alapat, E Tian, C Stein, R Khan, C J Heuck, N Petty, D Avery, D Steward, R Smith, C Bailey, J Epstein, S Yaccoby, A Hoering, J Crowley, G Morgan, B Barlogie and F van Rhee

Blood Cancer J 2016 6: e453; 10.1038/bcj.2016.64

Abstract | Full Text

Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia

S Kayser, A Benner, C Thiede, U Martens, J Huber, P Stadtherr, J W G Janssen, C Röllig, M J Uppenkamp, T Bochtler, U Hegenbart, G Ehninger, A D Ho, P Dreger and A Krämer

Blood Cancer J 2016 6: e449; 10.1038/bcj.2016.46

Abstract | Full Text

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

P Ravi, S Kumar, J T Larsen, W Gonsalves, F Buadi, M Q Lacy, R Go, A Dispenzieri, P Kapoor, J A Lust, D Dingli, Y Lin, S J Russell, N Leung, M A Gertz, R A Kyle, P L Bergsagel and S V Rajkumar

Blood Cancer J 2016 6: e454; 10.1038/bcj.2016.65

Abstract | Full Text

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells

K K Starheim, T Holien, K Misund, I Johansson, K A Baranowska, A-M Sponaas, H Hella, G Buene, A Waage, A Sundan and G Bjørkøy

Blood Cancer J 2016 6: e446; 10.1038/bcj.2016.56

Abstract | Full Text

First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation

M Wilhelm, M Smetak, P Reimer, E Geissinger, T Ruediger, B Metzner, N Schmitz, A Engert, K Schaefer-Eckart and J Birkmann

Blood Cancer J 2016 6: e452; 10.1038/bcj.2016.63

Abstract | Full Text

Letters to the Editor


Thrombotic microangiopathy during carfilzomib use: case series in Singapore

Y Chen, M Ooi, S F Lim, A Lin, J Lee, C Nagarajan, C Phipps, Y S Lee, N F Grigoropoulos, Z Lao, S Surendran, E M Teh, Y T Goh, W J Chng and S K Gopalakrishnan

Blood Cancer J 2016 6: e450; 10.1038/bcj.2016.62

Full Text

An open-label phase I dose-finding study of APR-246 in hematological malignancies

S Deneberg, H Cherif, V Lazarevic, P-O Andersson, M von Euler, G Juliusson and S Lehmann

Blood Cancer J 2016 6: e447; 10.1038/bcj.2016.60

Full Text

Allogeneic hematopoietic cell transplantation in patients greater than or equal to70 years: which patients may benefit?

S P Haen, M Pham, C Faul, D Dörfel, W Vogel, L Kanz and W A Bethge

Blood Cancer J 2016 6: e443; 10.1038/bcj.2016.54

Full Text

Search for familial clustering of cancer in monoclonal gammopathy of unknown significance

K Hemminki, A Försti, J Sundquist and X Li

Blood Cancer J 2016 6: e445; 10.1038/bcj.2016.58

Full Text

Double IGHV DNA gene rearrangements in CLL: influence of mixed-mutated and -unmutated rearrangements on outcomes in CLL

B Heyman, A D Volkheimer and J B Weinberg

Blood Cancer J 2016 6: e440; 10.1038/bcj.2016.49

Full Text

Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen

S J Jacobus, S V Rajkumar, M Weiss, A K Stewart, E A Stadtmauer, N S Callander, L M Dreosti, M Q Lacy and R Fonseca

Blood Cancer J 2016 6: e448; 10.1038/bcj.2016.55

Full Text

Reprogramming of Notch1-induced acute lymphoblastic leukemia cells into pluripotent stem cells in mice

H Zhang, H Cheng, Y Wang, Y Zheng, Y Liu, K Liu, J Xu, S Hao, W Yuan, T Zhao and T Cheng

Blood Cancer J 2016 6: e444; 10.1038/bcj.2016.57

Full Text

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group